Product overview
Type
Yellow Fever
Commercial Name
Stabilized Yellow Fever Vaccine
Manufacturer
Institut Pasteur de Dakar
Responsible NRA
Ministère de la Santé publique
Country
Senegal
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Ampoule
Number of Doses
10
Diluent
0.9% Sodium Chloride
Route of Administration
Intramuscular or Subcutaneous
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
20
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
1.3999999999999999 cm3/dose (in secondary packaging)